SI-BONE is a medical device manufacturer specializing in titanium implants and surgical instruments designed to treat sacroiliac joint and spinal fusion conditions. The company produces multiple implant variations, including the IFUSE line, which features porous titanium designs with different geometries to accommodate various surgical approaches and facilitate bone integration. SI-BONE distributes its products through a direct sales team and third-party partners, with operations across the United States and international markets.
1Y: 22.78 (+51.4%) · range 11.61–22.78
entry readiness 5 · NOT READY · exit proximity 38
Value area 15.61–20.02 · 1% of 120d volume overhead · clean runway
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.967 | Nov 3, 2026 |
Not yet labeled — the study prices these as positions mature.